FDA OKs Viltolarsen (Viltepso) for Duchenne Muscular Dystrophy FDA OKs Viltolarsen (Viltepso) for Duchenne Muscular Dystrophy

Viltolarsen is for patients with Duchenne muscular dystrophy with a confirmed mutation amenable to exon 53 skipping.FDA Approvals

Source: Medscape Neurology and Neurosurgery Headlines - August 13, 2020 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news